Infinity Pharmaceuticals (INFI)

13.00 +0.27 +2.12% May 29, 5:19PM Go Pro

Watch this stock

Infinity Pharmaceuticals Revenues: 25.20M

Add a financial metric

Switch to
Select a metric

View As % Change
Show US Recessions

Zoom:
1d
5d
1m
3m
6m
YTD
1y
5y
10y
Max

Date range: to

<Embed Chart> Pro Save as Image Pro Data Export

Attention OK

INFI Revenues Rankings

Overall	25th percentile	3314 of 4425
Sector	49th percentile	237 of 470 in Healthcare
Industry	70th percentile	39 of 132 in Biotechnology

INFI Revenues Range, Past 5 Years

Minimum	2.50M	Jun 2008
Maximum	67.19M	Dec 2008
Average	17.10M

About Revenues

Income that a company gains from business activities, calculated before any expenses are subtracted. Includes all sales and other increases in owner's equity.
Learn More

You may also be interested in these INFI related companies

Options

INFI News

INFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters t
May 18, 4:05PM

10 biotech securities will be added to the Nasdaq biotech index on May 21: $CERS $CLDX $FOLD $INFI $JAZZ $OMER $OREX $PCRX $RPTP $TSRX
about 14 days ago by abubnic

Infinity Added to NASDAQ Biotechnology Index
May 15, 8:06AM Benzinga

NASDAQ OMX (NDAQ) Adds 10 Stocks to NASDAQ Biotechnology Index (NBI)
May 14, 9:41AM Street Insider

NASDAQ Biotechnology Index - semi-annual changes
May 14, 7:25AM

$INFI $GNC $LQDT look good here.
about 19 days ago by Genyko

Jefferies Raises Price Target on Infinity Pharmaceuticals (INFI)
May 09, 2:04PM Street Insider

Infinity Pharmaceuticals, Inc. (INFI) Misses Q1 EPS by 3c
May 08, 4:52PM Street Insider

Listen to $INFI Q1 2012 earnings call - live at 04:30 PM, ondemand after - http://stks.co/3jHX
about 21 days ago by earningscast

INFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statement
May 08, 4:10PM

Infinity Reports First Quarter 2012 Financial Results
May 08, 4:00PM Business Wire

$INFI filed latest Quarterly Report http://stks.co/3jC9
about 21 days ago by MarketBrief

INFINITY PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report
May 08, 3:49PM

Q1 2012 Infinity Pharmaceuticals, Inc. Earnings Release - Time Not Supplied
May 08, 7:07AM

Infinity Announces the Date of Its First Quarter 2012 Financial Results Conference Call and Webcast
May 01, 8:00AM Business Wire

$INFI New 52 Week High - Crossed daily highs resistance.
about 29 days ago by TradeIdeasQuant

$INFI - Still long @ 12.02. Moving up the Stop to 10.43 from the Initial Stop of $8.84 - http://stks.co/3YpG
about 32 days ago by TraderFoxxx

$INFI http://stks.co/3Y2A long setup
about 33 days ago by stt2318

INFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Apr 20, 9:04AM

Just closed 5d holds: $NILE short +2.7% $FDO long +.7% $INFI short -2.6% $DMND long -7.4% for a rough day... http://stks.co/3LLD
about 46 days ago by TrendExhaustion

Infinity Pharmaceuticals to Present at Two Upcoming Conferences
Apr 13, 8:00AM Business Wire

$INFI filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3JVY
about 48 days ago by MarketBrief

$INFI filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3ITy
about 49 days ago by MarketBrief

TrendExhaustionPRO live SELLS: $AAPL $TLT $CNS $PSMT $LQDT $INFI $GEO $PCLN $HGIC $VVUS http://stks.co/3Hka
about 49 days ago by TrendExhaustion

$INFI filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3HFd
about 50 days ago by MarketBrief

TrendExhaustionPRO live SELL recommendations: $LQDT $SURW $PCLN $VVUS $AAPL $LNG $TLT $DFG $INFI $SRE http://stks.co/3Gj2
about 50 days ago by TrendExhaustion

$INFI filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3GIs
about 51 days ago by MarketBrief

$INFI filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3FX8
about 53 days ago by MarketBrief

TrendExhaustion current top SELLS: $MYE $INFI $VVUS $FDO $SOA $WOOF $TLEO $AIG $AVD $TNC http://stks.co/3EwM
about 54 days ago by TrendExhaustion

$INFI filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3El1
about 54 days ago by MarketBrief

$INFI filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3Day
about 55 days ago by MarketBrief

Noteworthy Institutional 5% Ownership Filings On Friday
Apr 02, 8:31AM

Infinity Pharma (INFI) Presented Encouraging Data for IPI-926 at AACR
Apr 02, 6:29AM Street Insider

Infinity Reports New Preclinical Data for Saridegib at AACR Supporting Development in Residual Disease Settings
Apr 01, 5:05PM Business Wire

Infinity Pharmaceuticals to Present at the 11th Annual Needham Healthcare Conference
Mar 28, 4:00PM Business Wire

Trade Signal-New $infi -BTO @ 12.02-Limit w/8.84-Stop on the Wkly Chart w/.5N @ Risk http://chart.ly/x6wr6sd
about 65 days ago by TraderFoxxx

$INFI Why is this going parabolic? Can't find any news. Pump and dump or higher prices to come?
about 68 days ago by Wally65

$INFI has closed its 5.3% down-gap.
about 70 days ago by TradeBot

Women to watch: Meet MHT's 2012 list of honorees
Mar 19, 3:07PM

INFINITY PHARMACEUTICALS, INC. Financials
Mar 17, 1:04PM

InPlay: Infinity Pharmaceutical Correction: INFI did not announce an expansion of a credit facility
Mar 15, 7:12AM

Jefferies Maintains a 'Buy' on Infinity Pharmaceutical (INFI); Wider Loss, But Sufficient Cash Through 1H13
Mar 14, 7:22AM Street Insider

INFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Change in Directors
Mar 13, 4:23PM

Listen to $INFI Q1 2012 earnings call - live at 04:30 PM, ondemand after - http://stks.co/2pPj
about 77 days ago by earningscast

Infinity Pharmaceuticals, Inc. (INFI) Misses Q4 EPS by 11c; Issues FY12 Loss Outlook
Mar 13, 4:10PM Street Insider

$INFI Provides Company Outlook; Reiterates 2012 Financial Guidance
about 77 days ago by Benzinga

Infinity Provides Company Outlook; Reiterates 2012 Financial Guidance
Mar 13, 4:04PM Benzinga

Infinity Provides Company Outlook and Reports Full-Year and Fourth Quarter 2011 Financial Results
Mar 13, 4:00PM Business Wire

$INFI filed latest Annual Report http://stks.co/2pL4
about 77 days ago by MarketBrief

INFINITY PHARMACEUTICALS, INC. Files SEC form 10-K, Annual Report
Mar 13, 3:54PM

Companies reporting After the Market Close on Tuesday, March 13
Mar 13, 3:13PM

Q1 2012 Infinity Pharmaceuticals, Inc. Earnings Release - Time Not Supplied
Mar 13, 7:07AM

Week Ahead Market Report: March 12, 2012
Mar 12, 12:49PM

[video] Week Ahead Market Report: March 12, 2012
Mar 12, 11:40AM

Infinity (INFI) Appoints Two New Independent Board Memebers
Mar 12, 8:11AM Street Insider

Infinity Appoints Two Experienced Industry Leaders to Its Board of Directors
Mar 12, 8:00AM Business Wire

1-Star Stocks Poised to Plunge: Infinity Pharmaceuticals?
Feb 29, 9:33AM Fool

Cloudant Names Andy Palmer to Its Board of Directors
Feb 27, 10:06AM Marketwire

Infinity Announces the Date of Its Fourth Quarter 2011 Financial Results Conference Call and Webcast
Feb 27, 8:00AM Business Wire

Infinity Pharmaceuticals to Present at Cowen Healthcare Conference
Feb 21, 8:00AM Business Wire

Infinity Pharmaceuticals Announces Its Participation at Three Investor Conferences
Feb 06, 8:00AM Business Wire

A.M. Vitals: J&J Shakes Up Oversight of McNeil Unit
Jan 31, 9:32AM

5 of Last Week's Biggest Losers
Jan 30, 9:56AM

UPDATE: Piper Jaffray Lowers PT on Infinity Pharmaceuticals to $8
Jan 27, 2:37PM Benzinga

Infinity Pharma downgraded to Hold from Buy at ThinkEquity
Jan 27, 2:05PM

Infinity plunges 40% on failed drug study
Jan 27, 12:24PM

Infinity Plummets on Disappointing Phase 2 Study
Jan 27, 10:58AM Benzinga

Piper Jaffray Lowers PT on Infinity Pharmaceuticals to $8
Jan 27, 10:28AM Benzinga

Infinity Pharma (INFI) Slammed, Will Stop Saridegib Phase 2 Based on Results
Jan 27, 9:54AM Street Insider

UPDATE 1-Infinity stops cancer trial as drug fails to show benefit
Jan 27, 7:23AM

INFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Jan 27, 6:55AM

Infinity Reports Update from Phase 2 Study of Saridegib Plus Gemcitabine in Patients with Metastatic Pancreatic Cancer
Jan 27, 6:47AM Benzinga

Infinity (INFI) Offers New Data from Phase 1b Trial of Saridegib
Jan 20, 2:49PM Street Insider

Infinity Reports New Data from Phase 1b Trial of Saridegib in Patients with Pancreatic Cancer at ASCO-GI
Jan 20, 2:45PM Benzinga

Recent Quotes

Symbol	Price	Chg	Chg %	Market Cap
INFI	13.00	+0.27	+2.12%	340.65M
INFA	43.23	+0.66	+1.55%	4.571B
INCY	22.38	-0.03	-0.13%	2.853B
INAP	7.17	+0.04	+0.56%	375.96M
IN	5.99	+0.44	+7.93%	332.06M
IMT	14.97	+0.01	+0.07%
IMS	14.55	-0.03	-0.21%
IMRS	3.17	+0.05	+1.60%	142.68M
IMOS	13.17	+0.58	+4.61%	338.92M
IMO	41.35	+0.91	+2.25%	34.28B

Create Watchlist from Stock Quotes